COCOS trial: COrticosteroids for COVID-19-induced loss of Smell–protocol for a single-centred, double-blind, randomised, placebo-controlled trial

Abstract

IntroductionHyposmia and anosmia are common in COVID-19. Most patients regain normal smell within 4 weeks, but severe loss of smell persists roughly in 20% after 2 months and may last...